Effects of SB 217242, a non-selective endothelin (ET)-A and ET-B receptor antagonist, in healthy humans.

被引：0
|
作者：
Freed, MI
Thompson, KA
Wilson, DE
Ohlstein, EH
Dennis, M
Jorkasky, DK
机构：
[1] SMITHKLINE BEECHAM PHARMACEUT, DEPT CLIN PHARMACOL, PHILADELPHIA, PA USA
[2] SMITHKLINE BEECHAM PHARMACEUT, DEPT CARDIOVASC PHARMACOL, PHILADELPHIA, PA USA
[3] SMITHKLINE BEECHAM PHARMACEUT, DEPT DRUG METAB & PHARMACOKINET, PHILADELPHIA, PA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A1558 / A1558
页数：1
相关论文
共 50 条
  • [41] The selective endothelin ET(A) receptor antagonist FR139317 inhibits neointimal thickening in the rat
    Takiguchi, Y
    Sogabe, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 309 (01) : 59 - 62
  • [42] Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia
    Oldner, A
    Wanecek, M
    Weitzberg, E
    Sundin, P
    Sollevi, A
    Rubio, C
    Hellström, PM
    Alving, K
    Rudehill, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (08) : 1793 - 1804
  • [43] Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo acute effects of Bosentan, an orally active, mixed endothelin ET(A) and ET(B) receptor antagonist
    Kaddoura, S
    Firth, JD
    Boheler, KR
    Sugden, PH
    PooleWilson, PA
    CIRCULATION, 1996, 93 (11) : 2068 - 2079
  • [44] ENDOTHELIN RECEPTOR SUBTYPES IN THE PATHOGENESIS OF ANGIOPLASTY-INDUCED NEOINTIMA FORMATION IN THE RAT - A COMPARISON OF SELECTIVE ET(A) RECEPTOR ANTAGONISM AND DUAL ET(A)/ET(B) RECEPTOR ANTAGONISM USING BQ-123 AND SB-204670
    DOUGLAS, SA
    VICKERYCLARK, LM
    LOUDEN, C
    ELLIOTT, JD
    OHLSTEIN, EH
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 : S186 - S189
  • [45] ANALYSIS OF VASOCONTRACTILE RESPONSES TO ENDOTHELIN-1 IN RABBIT RETINAL-VESSELS USING AN ET(A)-RECEPTOR ANTAGONIST AND AN ET(B)-RECEPTOR AGONIST
    TAKEI, K
    SATO, T
    NONOYAMA, T
    HOMMURA, S
    MIYAUCHI, T
    GOTO, K
    LIFE SCIENCES, 1993, 53 (06) : PL111 - PL115
  • [46] In vitro and in vivo effect of endothelin-1 (ET-1) and and ET-A selective endothelin receptor antagonist (ET-RA) on intestinal contractility in a rat model of acute pancreatitis
    Kolb, G
    Runkel, M
    Bössenrodt, K
    Foitzik, T
    Kirchengast, M
    Buhr, HJ
    LANGENBECKS ARCHIVES OF SURGERY, 1999, : 41 - 43
  • [47] Non-selective endothelin receptor antagonist, SB209670, reduces diet-induced hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice
    Iwasa, S
    Fan, JL
    Miyauchl, T
    Watanabe, T
    CIRCULATION, 1999, 100 (18) : 474 - 474
  • [48] The role of ET(B) receptors in normotensive and hypertensive rats as revealed by the non-peptide selective ET(B) receptor antagonist Ro 46-8443
    Clozel, M
    Breu, V
    FEBS LETTERS, 1996, 383 (1-2) : 42 - 45
  • [49] The effects of ET-1 and YM598, a novel selective endothelin ETA receptor antagonist, on the lower urinary tract
    Yuyama, H
    Fujimori, A
    Koakutsu, A
    Sanagi, M
    Ukai, M
    Ohtake, A
    Sato, S
    Sudoh, K
    Sasamata, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 252P - 252P
  • [50] Long-term effect of selective and non-selective oral endothelin-1 (ET-1) receptor antagonists in mice with heart failure (HF).
    Cavasin, MA
    Yang, XP
    Liu, YH
    Mehta, D
    Karumanchi, R
    Carretero, OA
    HYPERTENSION, 1999, 34 (02) : 348 - 348
12345